{"id":"https://openalex.org/W2907856378","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.3049","title":"A novel method for identifying downstream signals in tumor-reactive T cells following PD-1 engagement and monitoring endogenous tumor immunity and immunotherapy.","display_name":"A novel method for identifying downstream signals in tumor-reactive T cells following PD-1 engagement and monitoring endogenous tumor immunity and immunotherapy.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2907856378","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.3049","mag":"2907856378"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.3049","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.3049","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.3049","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038413156","display_name":"Haidong Dong","orcid":"https://orcid.org/0000-0002-5782-2983","observed_orcids":["https://orcid.org/0000-0002-5782-2983","https://orcid.org/0000-0001-8543-661X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haidong Dong","raw_affiliation_strings":["College of Medicine, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wei Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146387","display_name":"Guang\u2019anmen Hospital","ror":"https://ror.org/04gjmb875","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146387"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Zhao","raw_affiliation_strings":["Guang'an men Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guang'an men Hospital, Beijing, China","institution_ids":["https://openalex.org/I4210146387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027976630","display_name":"Christopher J. Krco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J Krco","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082719040","display_name":"Svetomir N. Markovic","orcid":"https://orcid.org/0000-0002-9238-4325","observed_orcids":["https://orcid.org/0000-0002-9238-4325"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svetomir Markovic","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071440718","display_name":"Aaron Scott Mansfield","orcid":"https://orcid.org/0000-0002-9483-6903","observed_orcids":["https://orcid.org/0000-0002-9483-6903"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Scott Mansfield","raw_affiliation_strings":["Department of Medical Oncology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109287755","display_name":"Kenneth R. Olivier","orcid":"https://orcid.org/0000-0002-3558-2341","observed_orcids":["https://orcid.org/0000-0002-3558-2341"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth R Olivier","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064556131","display_name":"Sean Sunghun Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128757","display_name":"Corewell Health William Beaumont University Hospital","ror":"https://ror.org/03artm726","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128757","https://openalex.org/I4392738273"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Sunghun Park","raw_affiliation_strings":["William Beaumont Hospital, Royal Oak, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"William Beaumont Hospital, Royal Oak, MI","institution_ids":["https://openalex.org/I4210128757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112904768","display_name":"Eugene D. Kwon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugene D. Kwon","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"3049","last_page":"3049"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8830000162124634},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9459999799728394},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-reactive-t-cells","display_name":"tumor-reactive T cells","score":0.8270000219345093},{"id":"https://openalex.org/keywords/pd-1-pd-l1-signaling","display_name":"PD-1/PD-L1 signaling","score":0.7329999804496765},{"id":"https://openalex.org/keywords/checkpoint-blockade","display_name":"checkpoint blockade","score":0.550000011920929},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8519999980926514},{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.9380000233650208},{"id":"https://openalex.org/keywords/soluble-pd-l1","display_name":"soluble PD-L1","score":0.7630000114440918},{"id":"https://openalex.org/keywords/t-cell-apoptosis","display_name":"T cell apoptosis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6959999799728394},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7269999980926514},{"id":"https://openalex.org/keywords/immunotherapy-response-monitoring","display_name":"immunotherapy response monitoring","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cd11a","display_name":"CD11a","score":0.6919999718666077},{"id":"https://openalex.org/keywords/survival-prediction","display_name":"survival prediction","score":0.6880000233650208},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7379971146583557},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6590381264686584},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5372011661529541},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5258075594902039},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5012342929840088},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.4975605309009552},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4922925531864166},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4908085763454437},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47463616728782654},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.47319862246513367},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4411030411720276},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42784184217453003},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4215688109397888},{"id":"https://openalex.org/C62084212","wikidata":"https://www.wikidata.org/wiki/Q3648604","display_name":"CD11a","level":5,"score":0.41951674222946167},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3315068185329437},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2978366017341614},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1263982653617859},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1106758713722229},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C53122370","wikidata":"https://www.wikidata.org/wiki/Q2458503","display_name":"CD18","level":4,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C171779818","wikidata":"https://www.wikidata.org/wiki/Q3799301","display_name":"Integrin alpha M","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.3049","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.3049","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.3049","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2346198650","https://openalex.org/W1570387459","https://openalex.org/W2588429392","https://openalex.org/W2755465191","https://openalex.org/W2904253493","https://openalex.org/W1982658780","https://openalex.org/W2890077431","https://openalex.org/W2613314461","https://openalex.org/W2617669081","https://openalex.org/W3083761008"],"abstract_inverted_index":{"3049":[0],"Background:":[1],"Therapies":[2],"targeting":[3],"programmed":[4],"cell":[5,125,305],"death":[6],"1":[7],"(PD-1)":[8],"or":[9,104,251],"its":[10,38],"ligand":[11,39],"B7-H1":[12,40,245],"(aka":[13],"PD-L1)":[14],"have":[15,50,243],"yielded":[16],"promising":[17],"therapeutic":[18],"effects":[19,297],"in":[20,87,112,130,152,156,173,198,207,281,287,322],"various":[21],"solid":[22],"and":[23,74,79,97,134,145,229,256,318],"hematologic":[24],"malignancies.":[25],"A":[26],"reliable":[27],"method":[28],"to":[29,138,259,277],"determine":[30],"whether":[31],"PD-1":[32,57,73,146,227,316],"on":[33,41,226,301],"T":[34,64,77,124,154,179,185,201,240,267,289,304],"cells":[35,43,65,78,155,180,186,202,241,268,275,280,290],"has":[36],"engaged":[37,122,244],"tumor":[42,279],"is":[44,224],"highly":[45],"desirable":[46],"as":[47,52,141,311],"it":[48],"may":[49,234,291,319,326],"significance":[51],"a":[53,84,270,312],"predictive":[54],"marker":[55],"for":[56,315],"targeted":[58],"therapy.":[59,331],"Methods:":[60],"Endogenous":[61],"tumor-reactive":[62],"CD8+":[63,76,123,153,178,200,239,266,288],"were":[66],"identified":[67],"by":[68,143],"their":[69,80],"high":[70,265],"expression":[71,81,149,233,286,308],"of":[72,82,91,195,237,273,298],"CD11a":[75,144,264],"Bim,":[83],"pro-apoptotic":[85],"molecule,":[86],"the":[88,174,182,191,199,221,293],"peripheral":[89],"blood":[90],"26":[92],"patients":[93,99,131,159,165,208,324],"with":[94,100,132,166,204,209],"metastatic":[95,101],"melanoma":[96,133,210],"11":[98],"prostate":[102,135],"cancer":[103,136,158,282],"healthy":[105,139,161,196],"donors":[106,197],"using":[107,117],"flow":[108],"cytometry.":[109],"Soluble":[110],"PD-L1":[111],"patients\u2019":[113],"sera":[114],"was":[115,127,150,170],"quantified":[116],"ELISA.":[118],"Results:":[119],"The":[120],"target-cell":[121],"population":[126,272],"significantly":[128,171],"higher":[129,151,172,231],"compared":[137],"donors,":[140],"assessed":[142],"expression.":[147],"Bim":[148,169,188,222,232,285,307],"both":[157],"than":[160,181],"controls":[162],"(p<0.01).":[163],"In":[164],"advanced":[167],"melanoma,":[168],"PD-1(+)":[175,238],"target":[176,278],"cell-engaged":[177],"PD-1(-)":[183],"CD-8+":[184],"(P<0.01).":[187],"levels":[189,194],"above":[190],"base":[192],"line":[193],"correlated":[203],"decreased":[205],"survival":[206],"(8.9":[211],"months":[212],"v.":[213],"13.8":[214],"months,":[215],"p<0.05).":[216],"Our":[217],"data":[218],"suggest":[219],"that":[220,230],"level":[223],"dependent":[225],"expression,":[228],"be":[235,320],"indicative":[236],"which":[242],"(PD-L1),":[246],"either":[247],"soluble":[248],"(peripheral":[249],"blood)":[250],"membrane":[252],"bound":[253],"(tumor":[254],"cells),":[255],"are":[257],"susceptible":[258],"apoptotic":[260],"death.":[261],"Conclusions:":[262],"PD-1+":[263],"identify":[269],"unique":[271],"effector":[274],"responsive":[276],"patients.":[283],"Elevated":[284],"indicate":[292],"active":[294],"immune":[295],"inhibiting":[296],"PD-1/B7-H1":[299],"signaling":[300,313],"endogenous":[302],"antitumor":[303],"responses.":[306],"can":[309],"serve":[310],"biomarker":[314],"function":[317],"useful":[321],"selecting":[323],"who":[325],"benefit":[327],"from":[328],"checkpoint":[329],"blockade":[330]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-01-11T00:00:00"}